Investigation of admission serum creatinine as a predictor of hospital length of stay in triple-vaccinated COVID-19 inpatients
© The Author(s) 2023. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene..
BACKGROUND: This study assessed the association between admission kidney function and the duration of hospitalization in triple-vaccinated coronavirus disease 2019 (COVID-19) inpatients during the omicron surge in Larissa, central Greece.
METHODS: Regression analysis was used to estimate the effect of kidney function biomarkers on hospital length of stay (LoS) within a dataset from a cohort of 51 subjects.
RESULTS: Sex- and age-adjusted admission serum creatinine was associated with hospital LoS (p=0.034).
CONCLUSIONS: Serum creatinine concentration on admission should be further evaluated as a possible clinical predictor of hospital LoS among triple-vaccinated COVID-19 inpatients both at the country and global level.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
|---|---|
| Enthalten in: |
International health - 16(2024), 1 vom: 02. Jan., Seite 117-119 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Rouka, Erasmia [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
AYI8EX34EU |
|---|
| Anmerkungen: |
Date Completed 03.01.2024 Date Revised 04.01.2024 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1093/inthealth/ihad008 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM352960566 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM352960566 | ||
| 003 | DE-627 | ||
| 005 | 20240108141547.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/inthealth/ihad008 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1248.xml |
| 035 | |a (DE-627)NLM352960566 | ||
| 035 | |a (NLM)36789478 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Rouka, Erasmia |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Investigation of admission serum creatinine as a predictor of hospital length of stay in triple-vaccinated COVID-19 inpatients |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 03.01.2024 | ||
| 500 | |a Date Revised 04.01.2024 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © The Author(s) 2023. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene. | ||
| 520 | |a BACKGROUND: This study assessed the association between admission kidney function and the duration of hospitalization in triple-vaccinated coronavirus disease 2019 (COVID-19) inpatients during the omicron surge in Larissa, central Greece | ||
| 520 | |a METHODS: Regression analysis was used to estimate the effect of kidney function biomarkers on hospital length of stay (LoS) within a dataset from a cohort of 51 subjects | ||
| 520 | |a RESULTS: Sex- and age-adjusted admission serum creatinine was associated with hospital LoS (p=0.034) | ||
| 520 | |a CONCLUSIONS: Serum creatinine concentration on admission should be further evaluated as a possible clinical predictor of hospital LoS among triple-vaccinated COVID-19 inpatients both at the country and global level | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a hospital length of stay | |
| 650 | 4 | |a inpatients | |
| 650 | 4 | |a quality metrics | |
| 650 | 4 | |a serum creatinine | |
| 650 | 4 | |a triple vaccinated | |
| 650 | 7 | |a Creatinine |2 NLM | |
| 650 | 7 | |a AYI8EX34EU |2 NLM | |
| 700 | 1 | |a Livanou, Eleni |e verfasserin |4 aut | |
| 700 | 1 | |a Sinis, Sotirios |e verfasserin |4 aut | |
| 700 | 1 | |a Dimeas, Ilias |e verfasserin |4 aut | |
| 700 | 1 | |a Pantazopoulos, Ioannis |e verfasserin |4 aut | |
| 700 | 1 | |a Papagiannis, Dimitrios |e verfasserin |4 aut | |
| 700 | 1 | |a Malli, Foteini |e verfasserin |4 aut | |
| 700 | 1 | |a Kotsiou, Ourania |e verfasserin |4 aut | |
| 700 | 1 | |a Gourgoulianis, Konstantinos I |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International health |d 2009 |g 16(2024), 1 vom: 02. Jan., Seite 117-119 |w (DE-627)NLM194756149 |x 1876-3405 |7 nnns |
| 773 | 1 | 8 | |g volume:16 |g year:2024 |g number:1 |g day:02 |g month:01 |g pages:117-119 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/inthealth/ihad008 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 16 |j 2024 |e 1 |b 02 |c 01 |h 117-119 | ||